NasdaqGM - Nasdaq Real Time Price USD
OnKure Therapeutics, Inc. (OKUR)
1.9200
-0.0800
(-4.00%)
At close: May 9 at 4:00:01 PM EDT
1.9200
0.00
(0.00%)
After hours: May 9 at 4:05:12 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | -1.26 | -1.29 | -4.66 | -3.19 |
| Low Estimate | -1.31 | -1.36 | -4.75 | -3.91 |
| High Estimate | -1.21 | -1.25 | -4.43 | -2.49 |
| Year Ago EPS | -- | -0.86 | -15.28 | -4.66 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | 666.67k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 2M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|
| EPS Est. | -0.9 | -0.87 | -1.38 |
| EPS Actual | -0.86 | -1.37 | -1.19 |
| Difference | 0.04 | -0.5 | 0.19 |
| Surprise % | 4.44% | -57.47% | 13.77% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.26 | -1.29 | -4.66 | -3.19 |
| 7 Days Ago | -1.42 | -1.4 | -5.16 | -3.52 |
| 30 Days Ago | -1.42 | -1.4 | -5.16 | -3.52 |
| 60 Days Ago | -1.07 | -1.11 | -3.42 | -1.83 |
| 90 Days Ago | -1.07 | -1.11 | -3.42 | -1.83 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 3 | 3 | -- | 3 |
| Down Last 30 Days | 3 | 3 | 4 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OKUR | -- | -50.58% | 69.47% | 31.55% |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/18/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 3/11/2025 |
| Initiated | Jones Trading: Buy | 1/28/2025 |
| Initiated | Leerink Partners: Outperform | 12/5/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/8/2024 |
| Initiated | Oppenheimer: Outperform | 10/10/2024 |
Related Tickers
EPIX ESSA Pharma Inc.
1.7200
+0.58%
HLVX HilleVax, Inc.
1.9000
-0.52%
KZR Kezar Life Sciences, Inc.
4.2200
+2.43%
PMVP PMV Pharmaceuticals, Inc.
0.8827
-0.12%
ANTX AN2 Therapeutics, Inc.
1.2000
-1.64%
GLTO Galecto, Inc.
2.7450
-1.96%
TBPH Theravance Biopharma, Inc.
8.98
-9.29%
SPRO Spero Therapeutics, Inc.
0.6200
+7.83%
ASMB Assembly Biosciences, Inc.
12.24
+4.97%
KROS Keros Therapeutics, Inc.
13.65
-2.64%